Reiner Kunze

Reiner Kunze

Auto-generated profile, based on publicly available information

Reiner Kunze

Institute of Physiology and Pathophysiology, Heidelberg University, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
PBPhilipp Barteczek
Philipp Barteczek
LLLexiao Li
Lexiao Li
AEAnne-Sophie Ernst
Anne-Sophie Ernst
LBLaura-Inés Böhler
Laura-Inés Böhler
HMHugo H Marti
Hugo H Marti
RKReiner Kunze
Reiner Kunze
Hypoxia-inducible factors mediate adaptive responses to ischemia, among others, by induction of anti- and pro-survival genes. Thus, the impact of HIF on neuronal survival upon stroke is controversial. Therefore, neuron-specific knockout mice deficient for Hif1a and Hif2a were exposed to inspiratory hypoxia or ischemia–reperfusion injury. Both Hif1a- and Hif2a-deficient mice showed no altered infarct and edema size, suggesting that both HIF-α subunits might compensate for each other. Accordingly, hypoxic HIF-target gene regulation was marginally affected with exception of anti-survival Bnip3 and pro-survival erythropoietin. In the early acute stage upon stroke, Hif1a/Hif2a double knockout mice exhibited significantly reduced expression of the anti-survival Bnip3, Bnip3L, and Pmaip1. Accordingly, global cell death and edema were significantly reduced upon 24 h but not 72 h reperfusion. Behavioral assessment indicated that Hif1a/Hif2a-deficient mice initially performed better, but became significantly more impaired after 72 h accompanied by increased apoptosis and reduced angiogenesis. Our findings suggest that in neurons HIF-1 and HIF-2 have redundant functions for cellular survival under ischemic conditions. By contrast, lack of anti-survival factors in Hif1a/Hif2a-deficient mice might protect from early acute neuronal cell death and neurological impairment, indicating a benefit of HIF-pathway inhibition in neurons in the very acute phase after ischemic stroke.

1 April 2015 in Experimental Neurology
Verified
Journal Article
Closed access
RKReiner Kunze
Reiner Kunze
AUAndres A. Urrutia
Andres A. Urrutia
AHAngelika Hoffmann
Angelika Hoffmann
HLHui Liu
Hui Liu
XHXavier Helluy
Xavier Helluy
HMHugo H. Marti
Hugo H. Marti

7 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRStefan Reischl
Stefan Reischl
LLLexiao Li
Lexiao Li
GWGail Walkinshaw
Gail Walkinshaw
LFLee A. Flippin
Lee A. Flippin
HMHugo H. Marti
Hugo H. Marti
RKReiner Kunze
Reiner Kunze
Ischemic stroke results in disruption of the blood-brain barrier (BBB), edema formation and neuronal cell loss. Some neuroprotective factors such as vascular endothelial growth factor (VEGF) favor edema formation, while others such as erythropoietin (Epo) can mitigate it. Both factors are controlled by hypoxia inducible transcription factors (HIF) and the activity of prolyl hydroxylase domain proteins (PHD). We hypothesize that activation of the adaptive hypoxic response by inhibition of PHD results in neuroprotection and prevention of vascular leakage. Mice, subjected to cerebral ischemia, were pre- or post-treated with the novel PHD inhibitor FG-4497. Inhibition of PHD activity resulted in HIF-1α stabilization, increased expression of VEGF and Epo, improved outcome from ischemic stroke and reduced edema formation by maintaining BBB integrity. Additional in vitro studies using brain endothelial cells and primary astrocytes confirmed that FG-4497 induces the HIF signaling pathway, leading to increased VEGF and Epo expression. In an in vitro ischemia model, using combined oxygen and glucose deprivation, FG-4497 promoted the survival of neurons. Furthermore, FG-4497 prevented the ischemia-induced rearrangement and gap formation of the tight junction proteins zonula occludens 1 and occludin, both in cultured endothelial cells and in infarcted brain tissue in vivo. These results indicate that FG-4497 has the potential to prevent cerebral ischemic damage by neuroprotection and prevention of vascular leakage.

1 October 2012 in Stroke
Verified
Journal Article
Closed access
PDF file
RKReiner Kunze
Reiner Kunze
WZWei Zhou
Wei Zhou
RVRoland Veltkamp
Roland Veltkamp
Ben WielockxBen Wielockx
Ben Wielockx
GBGeorg Breier
Georg Breier
HMHugo H. Marti
Hugo H. Marti
Background and Purpose—: Numerous factors involved in the adaptive response to hypoxia, including erythropoietin and vascular endothelial growth factor are transcriptionally regulated by hypoxia-inducible factors (HIFs). During normoxia, prolyl-4-hydroxylase domain (PHD) proteins hydroxylate HIF-α subunits, resulting in their degradation. We investigated the effect of neuronal deletion of PHD2, the most abundant isoform in brain, for stroke outcome. Methods—: We generated neuron-specific Phd2 knockout mice and subjected animals to systemic hypoxia or transient middle cerebral artery occlusion. Infarct volume and cell death were determined by histology. HIF-1α, HIF-2α, and HIF target genes were analyzed by immunoblotting and real-time polymerase chain reaction, respectively. Results—: Neuron-specific ablation of Phd2 significantly increased protein stability of HIF-1α and HIF-2α in the forebrain and enhanced expression of the neuroprotective HIF target genes erythropoietin and vascular endothelial growth factor as well as glucose transporter and glycolysis-related enzymes under hypoxic and ischemic conditions. Mice with Phd2 -deficient neurons subjected to transient cerebral ischemia exhibited a strong reduction in infarct size, and cell death of hippocampal CA1 neurons located in the peri-infarct region was dramatically reduced in these mice. Vessel density in forebrain subregions, except for caudate–putamen, was not altered in Phd2 -deficient animals. Conclusions—: Our findings denote that the endogenous adaptive response on hypoxic–ischemic insults in the brain is at least partly dependent on the activity of HIFs and identify PHD2 as the key regulator for the protective hypoxia response. The results suggest that specific inhibition of PHD2 may provide a useful therapeutic strategy to protect brain tissue from ischemic injury.

26 November 2009 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
RKReiner Kunze
Reiner Kunze
MRManuela Rösler
Manuela Rösler
SMStephanie Möller
Stephanie Möller
MSMatthias Schnabelrauch
Matthias Schnabelrauch
TRThomas Riemer
Thomas Riemer
PDPeter Dieter
Peter Dieter

7 August 2023 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
RKReiner Kunze
Reiner Kunze
Silvia FischerSilvia Fischer
Silvia Fischer
HMHugo H. Marti
Hugo H. Marti
Klaus T. PreissnerKlaus T. Preissner
Klaus T. Preissner
Neurological disorders such as stroke, multiple sclerosis, as well as the neurodegenerative diseases Parkinson's or Alzheimer's disease are accompanied or even powered by danger associated molecular patterns (DAMPs), defined as endogenous molecules released from stressed or damaged tissue. Besides protein-related DAMPs or “alarmins”, numerous nucleic acid DAMPs exist in body fluids, such as cell-free nuclear and mitochondrial DNA as well as different species of extracellular RNA, collectively termed as self-extracellular nucleic acids (SENAs). Among these, microRNA, long non-coding RNAs, circular RNAs and extracellular ribosomal RNA constitute the majority of RNA-based DAMPs. Upon tissue injury, necrosis or apoptosis, such SENAs are released from neuronal, immune and other cells predominantly in association with extracellular vesicles and may be translocated to target cells where they can induce intracellular regulatory pathways in gene transcription and translation. The majority of SENA-induced signaling reactions in the brain appear to be related to neuroinflammatory processes, often causally associated with the onset or progression of the respective disease. In this review, the impact of the diverse types of SENAs on neuroinflammatory and neurodegenerative diseases will be discussed. Based on the accumulating knowledge in this field, several specific antagonistic approaches are presented that could serve as therapeutic interventions to lower the pathological outcome of the indicated brain disorders.